{"id":"https://openalex.org/W3046694580","doi":"https://doi.org/10.1684/hma.2019.1464","title":"Minimal residual disease for multiple myeloma","display_name":"Minimal residual disease for multiple myeloma","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W3046694580","doi":"https://doi.org/10.1684/hma.2019.1464","mag":"3046694580"},"language":"en","primary_location":{"id":"pmh:oai:cairn.info:HMA_25S2_0036","doi":"https://doi.org/10.1684/hma.2019.1464","is_oa":true,"landing_page_url":"https://stm.cairn.info/revue-hematologie-2019-HS2-page-36?lang=fr","pdf_url":"https://stm.cairn.info/article/HMA_25S2_0036/pdf?lang=fr","source":{"id":"https://openalex.org/S4406923042","display_name":"Cairn.info","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405258322","host_organization_name":"Cairn.info","host_organization_lineage":["https://openalex.org/I4405258322"],"host_organization_lineage_names":[],"type":"other"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"H\u00e9matologie | 25 | N\u00b0 Supp 2 | 2019-06-01 | p. 36-39 | 1264-7527","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://stm.cairn.info/article/HMA_25S2_0036/pdf?lang=fr","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Avet\u2010Loiseau","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3050-0140","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030565933","display_name":"Jill Corre","orcid":"https://orcid.org/0000-0003-1580-6106","observed_orcids":["https://orcid.org/0000-0003-1580-6106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Corre","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1580-6106","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30849837,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"2","first_page":"36","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.972000002861023},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/recurrence-prediction","display_name":"recurrence prediction","score":0.7080000042915344},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7710000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.968999981880188},{"id":"https://openalex.org/keywords/flow-cytometry","display_name":"flow cytometry","score":0.7749999761581421},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.9639999866485596},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5854446887969971},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.4854581952095032},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.378495454788208},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3652937114238739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18692246079444885},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.12861531972885132}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:cairn.info:HMA_25S2_0036","doi":"https://doi.org/10.1684/hma.2019.1464","is_oa":true,"landing_page_url":"https://stm.cairn.info/revue-hematologie-2019-HS2-page-36?lang=fr","pdf_url":"https://stm.cairn.info/article/HMA_25S2_0036/pdf?lang=fr","source":{"id":"https://openalex.org/S4406923042","display_name":"Cairn.info","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405258322","host_organization_name":"Cairn.info","host_organization_lineage":["https://openalex.org/I4405258322"],"host_organization_lineage_names":[],"type":"other"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"H\u00e9matologie | 25 | N\u00b0 Supp 2 | 2019-06-01 | p. 36-39 | 1264-7527","raw_type":null},{"id":"mag:3046694580","doi":"https://doi.org/10.1684/hma.2019.1464","is_oa":false,"landing_page_url":"https://www.jle.com/en/revues/hma/e-docs/maladie_residuelle_dans_le_myelome_314857/article.phtml?tab=download&pj_key=doc_attach_42899","pdf_url":null,"source":{"id":"https://openalex.org/S4210211444","display_name":"H\u00e9matologie","issn_l":"1264-7527","issn":["1264-7527","1766-0327","1950-6368"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["jufo-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320125","host_organization_name":"John Libbey Eurotext","host_organization_lineage":["https://openalex.org/P4310320125"],"host_organization_lineage_names":["John Libbey Eurotext"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"H\u00e9matologie","raw_type":null}],"best_oa_location":{"id":"pmh:oai:cairn.info:HMA_25S2_0036","doi":"https://doi.org/10.1684/hma.2019.1464","is_oa":true,"landing_page_url":"https://stm.cairn.info/revue-hematologie-2019-HS2-page-36?lang=fr","pdf_url":"https://stm.cairn.info/article/HMA_25S2_0036/pdf?lang=fr","source":{"id":"https://openalex.org/S4406923042","display_name":"Cairn.info","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405258322","host_organization_name":"Cairn.info","host_organization_lineage":["https://openalex.org/I4405258322"],"host_organization_lineage_names":[],"type":"other"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"H\u00e9matologie | 25 | N\u00b0 Supp 2 | 2019-06-01 | p. 36-39 | 1264-7527","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3046694580.pdf","grobid_xml":"https://content.openalex.org/works/W3046694580.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2522940761","https://openalex.org/W2951533335","https://openalex.org/W4410547397","https://openalex.org/W2892241899","https://openalex.org/W3156741991","https://openalex.org/W3038802153","https://openalex.org/W3032343778","https://openalex.org/W3021476242","https://openalex.org/W7217256007","https://openalex.org/W3029531318"],"abstract_inverted_index":{"La":[0,57],"mesure":[1,45],"de":[2,27,31,36,46,63,107],"la":[3,47,54],"maladie":[4],"r\u00e9siduelle":[5],"(MRD)":[6],"rev\u00eat":[7],"un":[8,93],"int\u00e9r\u00eat":[9],"particulier":[10],"dans":[11,15,60,85],"le":[12,117],"my\u00e9lome":[13],"multiple,":[14],"lequel":[16],"les":[17,86],"rechutes":[18],"sont":[19],"fr\u00e9quentes,":[20],"que":[21],"ce":[22,78,112],"marqueur":[23,79],"permettrait":[24],"d\u2019anticiper":[25],"et":[26,35,71],"pr\u00e9venir.":[28],"Les":[29],"techniques":[30],"cytom\u00e9trie":[32],"en":[33,42,99],"flux":[34],"s\u00e9quen\u00e7age":[37],"\u00e0":[38,82],"haut":[39],"d\u00e9bit":[40],"permettent":[41],"effet":[43],"une":[44,50,67,72],"MRD":[48,58],"avec":[49,66],"sensibilit\u00e9":[51],"suffisante":[52],"pour":[53],"rendre":[55],"pr\u00e9dictive.":[56],"semble,":[59],"certaines":[61],"populations":[62],"patients,":[64],"corr\u00e9l\u00e9e":[65],"survie":[68,73],"sans":[69],"progression":[70],"globale":[74],"plus":[75,103],"longues.":[76],"Ainsi":[77],"a-t-il":[80],"vocation":[81],"\u00eatre":[83],"employ\u00e9":[84],"\u00e9tudes":[87],"cliniques,":[88],"o\u00f9":[89],"il":[90],"pourrait":[91],"constituer":[92],"objectif":[94],"principal":[95],";":[96],"son":[97],"utilisation":[98],"pratique":[100],"clinique":[101],"sera":[102],"satisfaisante":[104],"lorsqu\u2019il":[105],"permettra":[106],"piloter":[108],"l\u2019adaptation":[109],"des":[110],"traitements,":[111],"qui":[113],"n\u2019est":[114],"pas":[115],"encore":[116],"cas.":[118]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-08-07T00:00:00"}